| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Cirrhosis | 47 | 2026 | 58 | 11.870 |
Why?
|
| Liver Neoplasms | 31 | 2025 | 63 | 9.550 |
Why?
|
| Hepatic Stellate Cells | 34 | 2026 | 37 | 6.100 |
Why?
|
| Fatty Liver | 21 | 2025 | 59 | 5.680 |
Why?
|
| Animals | 117 | 2026 | 1875 | 5.530 |
Why?
|
| Liver | 40 | 2026 | 157 | 4.610 |
Why?
|
| Carcinoma, Hepatocellular | 20 | 2023 | 34 | 4.570 |
Why?
|
| Hepatocytes | 37 | 2026 | 85 | 4.320 |
Why?
|
| Mice | 85 | 2026 | 746 | 4.230 |
Why?
|
| Signal Transduction | 38 | 2020 | 246 | 4.120 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 12 | 2022 | 35 | 3.660 |
Why?
|
| Mice, Inbred C57BL | 46 | 2026 | 258 | 3.370 |
Why?
|
| Liver Diseases, Alcoholic | 10 | 2024 | 29 | 2.950 |
Why?
|
| Hyaluronic Acid | 6 | 2025 | 13 | 2.500 |
Why?
|
| Transforming Growth Factor beta | 11 | 2022 | 55 | 2.390 |
Why?
|
| Humans | 78 | 2026 | 6794 | 2.390 |
Why?
|
| Mice, Knockout | 36 | 2026 | 150 | 2.330 |
Why?
|
| Toll-Like Receptor 4 | 14 | 2019 | 16 | 2.210 |
Why?
|
| Ethanol | 8 | 2022 | 86 | 2.130 |
Why?
|
| Liver Diseases | 7 | 2023 | 19 | 2.090 |
Why?
|
| Kupffer Cells | 22 | 2025 | 22 | 2.040 |
Why?
|
| Apoptosis | 12 | 2019 | 179 | 2.010 |
Why?
|
| MicroRNAs | 6 | 2023 | 54 | 2.010 |
Why?
|
| Inflammation | 13 | 2024 | 143 | 1.980 |
Why?
|
| Disease Models, Animal | 18 | 2026 | 231 | 1.870 |
Why?
|
| Colorectal Neoplasms | 3 | 2025 | 23 | 1.870 |
Why?
|
| Toll-Like Receptor 9 | 4 | 2017 | 4 | 1.720 |
Why?
|
| Male | 61 | 2026 | 3671 | 1.700 |
Why?
|
| Tumor Microenvironment | 7 | 2025 | 25 | 1.680 |
Why?
|
| Toll-Like Receptor 2 | 8 | 2019 | 12 | 1.680 |
Why?
|
| Macrophages | 9 | 2025 | 40 | 1.580 |
Why?
|
| MAP Kinase Kinase Kinases | 5 | 2019 | 7 | 1.520 |
Why?
|
| Liver Neoplasms, Experimental | 7 | 2021 | 11 | 1.460 |
Why?
|
| Hyaluronan Synthases | 3 | 2022 | 4 | 1.390 |
Why?
|
| Diet, High-Fat | 5 | 2024 | 59 | 1.370 |
Why?
|
| Cancer-Associated Fibroblasts | 3 | 2025 | 4 | 1.240 |
Why?
|
| Adaptor Proteins, Signal Transducing | 11 | 2025 | 19 | 1.230 |
Why?
|
| Membrane Glycoproteins | 9 | 2020 | 65 | 1.230 |
Why?
|
| Chemical and Drug Induced Liver Injury | 6 | 2019 | 14 | 1.220 |
Why?
|
| Obesity | 5 | 2022 | 226 | 1.110 |
Why?
|
| NF-kappa B | 9 | 2020 | 56 | 1.060 |
Why?
|
| Cytokines | 9 | 2015 | 80 | 1.060 |
Why?
|
| Insulin Resistance | 5 | 2026 | 74 | 1.060 |
Why?
|
| Toll-Like Receptors | 11 | 2018 | 16 | 1.040 |
Why?
|
| Neoplasm Proteins | 2 | 2025 | 18 | 1.040 |
Why?
|
| Lipid Metabolism | 6 | 2014 | 33 | 1.010 |
Why?
|
| Autophagy | 5 | 2021 | 29 | 1.000 |
Why?
|
| CARD Signaling Adaptor Proteins | 2 | 2026 | 2 | 0.980 |
Why?
|
| Fibrosis | 6 | 2023 | 53 | 0.970 |
Why?
|
| Inflammasomes | 4 | 2019 | 10 | 0.960 |
Why?
|
| Dysbiosis | 1 | 2026 | 10 | 0.960 |
Why?
|
| Gene Expression Regulation | 9 | 2023 | 120 | 0.950 |
Why?
|
| Extracellular Matrix | 3 | 2023 | 22 | 0.950 |
Why?
|
| Cell Proliferation | 10 | 2025 | 143 | 0.950 |
Why?
|
| Choline Deficiency | 5 | 2021 | 6 | 0.900 |
Why?
|
| Receptors, Chemokine | 2 | 2018 | 3 | 0.880 |
Why?
|
| Carcinogenesis | 5 | 2021 | 11 | 0.880 |
Why?
|
| Drug Repositioning | 1 | 2024 | 1 | 0.870 |
Why?
|
| Liver Regeneration | 8 | 2012 | 10 | 0.840 |
Why?
|
| Hymecromone | 2 | 2021 | 2 | 0.830 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2014 | 6 | 0.820 |
Why?
|
| Lipopolysaccharides | 14 | 2019 | 41 | 0.810 |
Why?
|
| Intestinal Mucosa | 3 | 2024 | 17 | 0.790 |
Why?
|
| Extracellular Vesicles | 1 | 2023 | 6 | 0.790 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2021 | 10 | 0.790 |
Why?
|
| Toll-Like Receptor 7 | 2 | 2020 | 2 | 0.780 |
Why?
|
| Serine Endopeptidases | 1 | 2023 | 10 | 0.780 |
Why?
|
| Gastrointestinal Tract | 2 | 2014 | 6 | 0.780 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2021 | 11 | 0.770 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2022 | 1 | 0.770 |
Why?
|
| Female | 28 | 2022 | 4060 | 0.760 |
Why?
|
| Mitochondria, Liver | 2 | 2019 | 5 | 0.760 |
Why?
|
| Mice, Transgenic | 15 | 2024 | 59 | 0.750 |
Why?
|
| Liver Cirrhosis, Experimental | 4 | 2010 | 4 | 0.730 |
Why?
|
| Interleukins | 2 | 2025 | 8 | 0.730 |
Why?
|
| Interleukin-1beta | 5 | 2019 | 9 | 0.710 |
Why?
|
| Receptors, CCR2 | 2 | 2012 | 4 | 0.670 |
Why?
|
| Cells, Cultured | 17 | 2018 | 234 | 0.670 |
Why?
|
| Methionine Adenosyltransferase | 5 | 2024 | 8 | 0.660 |
Why?
|
| Polysaccharides | 2 | 2024 | 3 | 0.660 |
Why?
|
| Up-Regulation | 10 | 2019 | 94 | 0.660 |
Why?
|
| Down-Regulation | 2 | 2018 | 57 | 0.660 |
Why?
|
| Receptors, Immunologic | 5 | 2005 | 6 | 0.650 |
Why?
|
| Antigens, Differentiation | 5 | 2005 | 6 | 0.650 |
Why?
|
| Interferon Regulatory Factor-1 | 2 | 2019 | 2 | 0.650 |
Why?
|
| Endothelial Cells | 1 | 2020 | 17 | 0.640 |
Why?
|
| MafG Transcription Factor | 2 | 2018 | 2 | 0.620 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2020 | 88 | 0.620 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2026 | 26 | 0.610 |
Why?
|
| Proteolysis | 1 | 2019 | 5 | 0.610 |
Why?
|
| Neutrophil Infiltration | 3 | 2015 | 5 | 0.610 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2019 | 17 | 0.610 |
Why?
|
| Colonic Neoplasms | 1 | 2019 | 4 | 0.610 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 8 | 0.600 |
Why?
|
| Cell Line, Tumor | 9 | 2025 | 156 | 0.600 |
Why?
|
| Gene Deletion | 4 | 2013 | 17 | 0.590 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2021 | 19 | 0.580 |
Why?
|
| NF-kappa B p50 Subunit | 3 | 2018 | 4 | 0.580 |
Why?
|
| Chemokines | 2 | 2018 | 11 | 0.570 |
Why?
|
| Membrane Proteins | 2 | 2018 | 48 | 0.550 |
Why?
|
| Carbon Tetrachloride | 8 | 2024 | 8 | 0.540 |
Why?
|
| Myofibroblasts | 2 | 2015 | 7 | 0.540 |
Why?
|
| Myeloid Differentiation Factor 88 | 9 | 2015 | 11 | 0.540 |
Why?
|
| Cellular Senescence | 2 | 2015 | 8 | 0.530 |
Why?
|
| Tumor Necrosis Factor-alpha | 9 | 2019 | 48 | 0.520 |
Why?
|
| Pyridines | 2 | 2020 | 24 | 0.520 |
Why?
|
| MAP Kinase Signaling System | 2 | 2014 | 11 | 0.510 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2023 | 18 | 0.510 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2016 | 4 | 0.490 |
Why?
|
| Fatty Acids | 2 | 2014 | 25 | 0.490 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 2016 | 2 | 0.480 |
Why?
|
| Anilides | 1 | 2016 | 5 | 0.480 |
Why?
|
| Hedgehog Proteins | 1 | 2016 | 6 | 0.480 |
Why?
|
| Exosomes | 1 | 2016 | 7 | 0.480 |
Why?
|
| Bile Acids and Salts | 1 | 2015 | 12 | 0.470 |
Why?
|
| Cell Communication | 3 | 2026 | 11 | 0.470 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2016 | 41 | 0.460 |
Why?
|
| Chemokine CXCL1 | 1 | 2015 | 4 | 0.460 |
Why?
|
| Hepatitis | 1 | 2015 | 2 | 0.450 |
Why?
|
| RNA, Messenger | 9 | 2022 | 190 | 0.440 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 100 | 0.440 |
Why?
|
| Deoxycholic Acid | 1 | 2014 | 1 | 0.420 |
Why?
|
| Receptors, Cell Surface | 5 | 2005 | 29 | 0.410 |
Why?
|
| Pancreatitis-Associated Proteins | 2 | 2026 | 3 | 0.410 |
Why?
|
| Drosophila Proteins | 3 | 2002 | 9 | 0.410 |
Why?
|
| Cholestasis | 5 | 2018 | 7 | 0.390 |
Why?
|
| DNA, Neoplasm | 1 | 2013 | 6 | 0.390 |
Why?
|
| Palmitic Acid | 1 | 2013 | 3 | 0.390 |
Why?
|
| Forkhead Box Protein M1 | 2 | 2024 | 2 | 0.390 |
Why?
|
| Carbon Tetrachloride Poisoning | 4 | 2010 | 4 | 0.390 |
Why?
|
| Mitochondria | 4 | 2024 | 37 | 0.380 |
Why?
|
| Biomarkers | 6 | 2023 | 214 | 0.370 |
Why?
|
| TOR Serine-Threonine Kinases | 5 | 2019 | 14 | 0.370 |
Why?
|
| Monocytes | 1 | 2012 | 14 | 0.370 |
Why?
|
| Cholangiocarcinoma | 3 | 2021 | 3 | 0.350 |
Why?
|
| Collagen Type I | 6 | 2021 | 18 | 0.350 |
Why?
|
| Interleukin-18 | 6 | 2004 | 8 | 0.350 |
Why?
|
| Fatty Liver, Alcoholic | 1 | 2011 | 2 | 0.350 |
Why?
|
| Bone Marrow | 1 | 2011 | 4 | 0.350 |
Why?
|
| Disease Progression | 5 | 2023 | 170 | 0.340 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 2 | 2022 | 3 | 0.340 |
Why?
|
| Chemokine CX3CL1 | 1 | 2010 | 1 | 0.330 |
Why?
|
| Reactive Oxygen Species | 8 | 2016 | 45 | 0.330 |
Why?
|
| Mitochondrial Proteins | 2 | 2022 | 15 | 0.330 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2021 | 2 | 0.320 |
Why?
|
| Mice, Inbred BALB C | 12 | 2018 | 46 | 0.320 |
Why?
|
| STAT3 Transcription Factor | 3 | 2014 | 16 | 0.320 |
Why?
|
| Bile Duct Neoplasms | 2 | 2021 | 2 | 0.310 |
Why?
|
| Phosphorylation | 5 | 2022 | 73 | 0.310 |
Why?
|
| Receptors, CCR1 | 1 | 2009 | 1 | 0.310 |
Why?
|
| Receptors, CCR5 | 1 | 2009 | 2 | 0.310 |
Why?
|
| Interleukin-12 | 6 | 2004 | 7 | 0.300 |
Why?
|
| Repressor Proteins | 3 | 2018 | 13 | 0.300 |
Why?
|
| Hyaluronan Receptors | 2 | 2019 | 5 | 0.290 |
Why?
|
| Risk Factors | 3 | 2024 | 767 | 0.290 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 2 | 2007 | 2 | 0.280 |
Why?
|
| S-Adenosylmethionine | 3 | 2024 | 17 | 0.280 |
Why?
|
| Gene Expression Profiling | 4 | 2021 | 44 | 0.280 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2025 | 23 | 0.270 |
Why?
|
| ErbB Receptors | 1 | 2007 | 13 | 0.270 |
Why?
|
| Neoplasm Metastasis | 2 | 2025 | 22 | 0.270 |
Why?
|
| Collagen | 4 | 2022 | 31 | 0.260 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2019 | 17 | 0.260 |
Why?
|
| Smad Proteins | 2 | 2019 | 10 | 0.260 |
Why?
|
| Multiprotein Complexes | 3 | 2016 | 3 | 0.250 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2026 | 2 | 0.240 |
Why?
|
| alpha 1-Antitrypsin | 2 | 2025 | 2 | 0.240 |
Why?
|
| NADPH Oxidases | 3 | 2011 | 14 | 0.240 |
Why?
|
| Time Factors | 6 | 2015 | 321 | 0.240 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2025 | 1 | 0.240 |
Why?
|
| Phosphodiesterase 4 Inhibitors | 1 | 2025 | 1 | 0.240 |
Why?
|
| Interleukin-1 | 3 | 2004 | 12 | 0.240 |
Why?
|
| Listeria monocytogenes | 2 | 2002 | 3 | 0.230 |
Why?
|
| Immunity, Innate | 4 | 2011 | 20 | 0.230 |
Why?
|
| Synechococcus | 1 | 2025 | 1 | 0.230 |
Why?
|
| Aptamers, Nucleotide | 1 | 2025 | 1 | 0.230 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2025 | 2 | 0.230 |
Why?
|
| Aging | 1 | 2026 | 105 | 0.230 |
Why?
|
| Ligation | 9 | 2016 | 14 | 0.230 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2015 | 64 | 0.230 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2025 | 6 | 0.230 |
Why?
|
| Neoplastic Stem Cells | 2 | 2016 | 24 | 0.220 |
Why?
|
| Prostatic Neoplasms | 1 | 2025 | 45 | 0.220 |
Why?
|
| Analgesics | 1 | 2024 | 12 | 0.220 |
Why?
|
| Sirolimus | 2 | 2014 | 6 | 0.220 |
Why?
|
| Interleukin-6 | 5 | 2014 | 45 | 0.210 |
Why?
|
| Bile Ducts | 7 | 2024 | 7 | 0.210 |
Why?
|
| Cell Line | 4 | 2022 | 124 | 0.210 |
Why?
|
| Caspase 1 | 4 | 2013 | 4 | 0.210 |
Why?
|
| Endopeptidases | 3 | 2018 | 9 | 0.200 |
Why?
|
| TRPV Cation Channels | 1 | 2023 | 7 | 0.190 |
Why?
|
| Workflow | 1 | 2023 | 7 | 0.190 |
Why?
|
| Research | 1 | 2023 | 26 | 0.190 |
Why?
|
| HSP47 Heat-Shock Proteins | 1 | 2022 | 1 | 0.190 |
Why?
|
| Cyclins | 1 | 2022 | 7 | 0.190 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2022 | 8 | 0.190 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2014 | 28 | 0.190 |
Why?
|
| Neovascularization, Pathologic | 3 | 2015 | 23 | 0.190 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 22 | 0.190 |
Why?
|
| Protein Kinase C | 1 | 2022 | 31 | 0.190 |
Why?
|
| Hepatitis B, Chronic | 1 | 2022 | 1 | 0.190 |
Why?
|
| Chemokine CCL3 | 1 | 2022 | 1 | 0.190 |
Why?
|
| Chemokine CCL4 | 1 | 2022 | 1 | 0.190 |
Why?
|
| Models, Biological | 2 | 2021 | 64 | 0.180 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2019 | 35 | 0.180 |
Why?
|
| Chemokine CCL5 | 2 | 2019 | 4 | 0.180 |
Why?
|
| Pore Forming Cytotoxic Proteins | 2 | 2020 | 6 | 0.180 |
Why?
|
| Genetic Therapy | 3 | 2007 | 13 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2019 | 27 | 0.180 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2021 | 2 | 0.180 |
Why?
|
| Amino Acids | 2 | 2021 | 15 | 0.180 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2021 | 4 | 0.170 |
Why?
|
| Cell Movement | 3 | 2010 | 38 | 0.170 |
Why?
|
| Connexin 43 | 1 | 2021 | 2 | 0.170 |
Why?
|
| Indicators and Reagents | 1 | 2021 | 2 | 0.170 |
Why?
|
| Choline | 1 | 2021 | 7 | 0.170 |
Why?
|
| Bacteroides | 1 | 2020 | 1 | 0.170 |
Why?
|
| Tight Junctions | 1 | 2020 | 2 | 0.170 |
Why?
|
| Polyethylene Glycols | 1 | 2020 | 4 | 0.170 |
Why?
|
| Adipose Tissue | 1 | 2021 | 69 | 0.170 |
Why?
|
| Ligands | 1 | 2020 | 17 | 0.170 |
Why?
|
| Lactobacillus | 1 | 2020 | 6 | 0.170 |
Why?
|
| Administration, Oral | 1 | 2020 | 54 | 0.170 |
Why?
|
| Hepatocyte Growth Factor | 3 | 2026 | 3 | 0.170 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 3 | 2016 | 4 | 0.170 |
Why?
|
| Sphingomyelin Phosphodiesterase | 2 | 2010 | 2 | 0.160 |
Why?
|
| Biological Assay | 2 | 2021 | 4 | 0.160 |
Why?
|
| Proteins | 1 | 2020 | 41 | 0.160 |
Why?
|
| Middle Aged | 11 | 2021 | 2108 | 0.160 |
Why?
|
| Liver Failure | 2 | 2014 | 3 | 0.160 |
Why?
|
| Cell Survival | 3 | 2016 | 33 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 3 | 2020 | 45 | 0.160 |
Why?
|
| Sequestosome-1 Protein | 2 | 2016 | 3 | 0.150 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2019 | 1 | 0.150 |
Why?
|
| Chemokine CXCL10 | 1 | 2019 | 1 | 0.150 |
Why?
|
| HEK293 Cells | 1 | 2019 | 16 | 0.150 |
Why?
|
| Biopsy | 5 | 2022 | 36 | 0.150 |
Why?
|
| Hepacivirus | 3 | 2013 | 9 | 0.150 |
Why?
|
| Dendritic Cells | 3 | 2015 | 23 | 0.150 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 2 | 0.150 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2019 | 2 | 0.150 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2019 | 2 | 0.150 |
Why?
|
| Heat-Shock Proteins | 2 | 2016 | 9 | 0.150 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 7 | 0.150 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2018 | 1 | 0.150 |
Why?
|
| Sex Distribution | 1 | 2019 | 44 | 0.150 |
Why?
|
| Sirtuin 1 | 1 | 2018 | 8 | 0.150 |
Why?
|
| Oxygen Consumption | 1 | 2018 | 13 | 0.150 |
Why?
|
| Interleukin-8 | 1 | 2018 | 10 | 0.150 |
Why?
|
| Genomics | 1 | 2018 | 13 | 0.140 |
Why?
|
| Oxidation-Reduction | 2 | 2018 | 19 | 0.140 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 1 | 0.140 |
Why?
|
| DNA, Mitochondrial | 1 | 2018 | 9 | 0.140 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 8 | 0.140 |
Why?
|
| Biomarkers, Tumor | 1 | 2018 | 51 | 0.140 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 29 | 0.140 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2016 | 3 | 0.140 |
Why?
|
| Cell Death | 3 | 2016 | 20 | 0.140 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 98 | 0.140 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2025 | 38 | 0.130 |
Why?
|
| Hepatic Duct, Common | 1 | 2016 | 1 | 0.130 |
Why?
|
| Keratins, Type I | 1 | 2016 | 1 | 0.130 |
Why?
|
| Hepatitis, Alcoholic | 1 | 2016 | 4 | 0.130 |
Why?
|
| Genes, Reporter | 2 | 2014 | 13 | 0.130 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2019 | 11 | 0.120 |
Why?
|
| Phenotype | 2 | 2015 | 91 | 0.120 |
Why?
|
| Weight Loss | 2 | 2014 | 35 | 0.120 |
Why?
|
| Chemokine CCL2 | 2 | 2016 | 12 | 0.120 |
Why?
|
| Serum Amyloid A Protein | 1 | 2016 | 2 | 0.120 |
Why?
|
| Twins, Dizygotic | 1 | 2015 | 1 | 0.120 |
Why?
|
| Heredity | 1 | 2015 | 2 | 0.120 |
Why?
|
| Twins, Monozygotic | 1 | 2015 | 8 | 0.120 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2015 | 1 | 0.110 |
Why?
|
| Binge Drinking | 1 | 2015 | 4 | 0.110 |
Why?
|
| Sulfoglycosphingolipids | 1 | 2015 | 1 | 0.110 |
Why?
|
| Natural Killer T-Cells | 1 | 2015 | 2 | 0.110 |
Why?
|
| Retinoids | 1 | 2015 | 4 | 0.110 |
Why?
|
| Isoenzymes | 3 | 2025 | 15 | 0.110 |
Why?
|
| Blood Platelets | 1 | 2015 | 9 | 0.110 |
Why?
|
| Microbiota | 1 | 2015 | 8 | 0.110 |
Why?
|
| Lymphocytes | 1 | 2015 | 17 | 0.110 |
Why?
|
| Dactinomycin | 1 | 2014 | 2 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 1 | 2014 | 7 | 0.110 |
Why?
|
| Overnutrition | 1 | 2014 | 4 | 0.110 |
Why?
|
| Vesicular Transport Proteins | 1 | 2014 | 3 | 0.110 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 7 | 0.110 |
Why?
|
| Reperfusion Injury | 1 | 2014 | 7 | 0.110 |
Why?
|
| Interferon Type I | 1 | 2014 | 1 | 0.110 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2014 | 2 | 0.110 |
Why?
|
| PPAR alpha | 1 | 2014 | 9 | 0.110 |
Why?
|
| Cytosol | 2 | 2018 | 26 | 0.110 |
Why?
|
| Triglycerides | 2 | 2011 | 58 | 0.110 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 2009 | 6 | 0.110 |
Why?
|
| Histone Deacetylase 1 | 1 | 2014 | 1 | 0.100 |
Why?
|
| DNA Repair | 1 | 2014 | 7 | 0.100 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2014 | 1 | 0.100 |
Why?
|
| Haploinsufficiency | 1 | 2014 | 1 | 0.100 |
Why?
|
| Protein Multimerization | 1 | 2014 | 3 | 0.100 |
Why?
|
| Glucose Intolerance | 1 | 2014 | 7 | 0.100 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2013 | 3 | 0.100 |
Why?
|
| Calgranulin B | 1 | 2013 | 1 | 0.100 |
Why?
|
| Chemokine CXCL2 | 1 | 2013 | 2 | 0.100 |
Why?
|
| Chemical and Drug Induced Liver Injury, Chronic | 1 | 2013 | 2 | 0.100 |
Why?
|
| Cytoskeletal Proteins | 2 | 2023 | 6 | 0.100 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 12 | 0.100 |
Why?
|
| Aged | 5 | 2021 | 1539 | 0.100 |
Why?
|
| Autocrine Communication | 1 | 2013 | 1 | 0.100 |
Why?
|
| Listeriosis | 2 | 2004 | 3 | 0.100 |
Why?
|
| Coculture Techniques | 2 | 2010 | 9 | 0.100 |
Why?
|
| Plasmodium berghei | 2 | 2004 | 2 | 0.100 |
Why?
|
| Malaria | 2 | 2004 | 3 | 0.100 |
Why?
|
| Hepatitis, Animal | 2 | 2004 | 3 | 0.100 |
Why?
|
| Interleukin-1alpha | 1 | 2013 | 1 | 0.100 |
Why?
|
| Enzyme Precursors | 2 | 2004 | 6 | 0.100 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 15 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2012 | 1 | 0.100 |
Why?
|
| Caspases | 2 | 2004 | 29 | 0.100 |
Why?
|
| Killer Cells, Natural | 4 | 2011 | 35 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 72 | 0.100 |
Why?
|
| Rats | 5 | 2016 | 571 | 0.100 |
Why?
|
| Primary Graft Dysfunction | 1 | 2012 | 1 | 0.090 |
Why?
|
| Liver Transplantation | 1 | 2012 | 8 | 0.090 |
Why?
|
| Acetaminophen | 1 | 2012 | 9 | 0.090 |
Why?
|
| Chemokine CXCL12 | 1 | 2012 | 2 | 0.090 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 8 | 0.090 |
Why?
|
| Diethylnitrosamine | 3 | 2018 | 4 | 0.090 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2012 | 12 | 0.090 |
Why?
|
| Mice, Nude | 2 | 2025 | 41 | 0.090 |
Why?
|
| Alanine Transaminase | 2 | 2009 | 10 | 0.090 |
Why?
|
| Chronic Disease | 2 | 2014 | 167 | 0.090 |
Why?
|
| Bacterial Translocation | 1 | 2011 | 2 | 0.090 |
Why?
|
| Metagenome | 1 | 2011 | 4 | 0.090 |
Why?
|
| Metabolic Syndrome | 1 | 2012 | 35 | 0.090 |
Why?
|
| Tryptophan | 1 | 2011 | 5 | 0.090 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2011 | 1 | 0.090 |
Why?
|
| Blotting, Western | 3 | 2022 | 110 | 0.090 |
Why?
|
| Adult | 5 | 2019 | 2113 | 0.090 |
Why?
|
| Central Nervous System Depressants | 1 | 2011 | 14 | 0.090 |
Why?
|
| Nucleic Acid Conformation | 1 | 2010 | 1 | 0.080 |
Why?
|
| 5' Untranslated Regions | 1 | 2010 | 1 | 0.080 |
Why?
|
| RNA Stability | 1 | 2010 | 3 | 0.080 |
Why?
|
| DNA | 2 | 2007 | 39 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 40 | 0.080 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2010 | 2 | 0.080 |
Why?
|
| Diet | 1 | 2012 | 111 | 0.080 |
Why?
|
| Interleukin-10 | 1 | 2010 | 10 | 0.080 |
Why?
|
| Hep G2 Cells | 2 | 2022 | 7 | 0.080 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 2 | 2007 | 2 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2016 | 282 | 0.080 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2010 | 1 | 0.080 |
Why?
|
| Cell Division | 1 | 2009 | 40 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2009 | 8 | 0.080 |
Why?
|
| CCR5 Receptor Antagonists | 1 | 2009 | 1 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2009 | 1 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2009 | 3 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2009 | 39 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2009 | 11 | 0.070 |
Why?
|
| Leptin | 1 | 2008 | 21 | 0.070 |
Why?
|
| Primary Cell Culture | 2 | 2020 | 10 | 0.070 |
Why?
|
| Angiopoietin-1 | 1 | 2008 | 1 | 0.070 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2008 | 1 | 0.070 |
Why?
|
| RNA Helicases | 1 | 2008 | 3 | 0.070 |
Why?
|
| Hepatitis C, Chronic | 1 | 2008 | 4 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2022 | 681 | 0.070 |
Why?
|
| Acute Disease | 1 | 2008 | 91 | 0.070 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2007 | 2 | 0.070 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2007 | 1 | 0.070 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 2007 | 1 | 0.070 |
Why?
|
| Common Bile Duct | 1 | 2007 | 1 | 0.070 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2007 | 3 | 0.070 |
Why?
|
| Rectal Neoplasms | 1 | 2007 | 3 | 0.070 |
Why?
|
| Colonoscopy | 1 | 2007 | 10 | 0.070 |
Why?
|
| Cell Cycle | 1 | 2007 | 16 | 0.070 |
Why?
|
| Mice, Inbred C3H | 1 | 2007 | 39 | 0.070 |
Why?
|
| Oligonucleotides | 1 | 2007 | 5 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2007 | 50 | 0.070 |
Why?
|
| Antigens, CD1 | 2 | 2004 | 3 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2004 | 7 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2007 | 28 | 0.060 |
Why?
|
| Collagenases | 1 | 2006 | 3 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2015 | 331 | 0.060 |
Why?
|
| DNA Damage | 2 | 2018 | 20 | 0.060 |
Why?
|
| Single-Cell Analysis | 1 | 2026 | 2 | 0.060 |
Why?
|
| Gastric Bypass | 1 | 2006 | 5 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 2004 | 23 | 0.060 |
Why?
|
| Obesity, Morbid | 1 | 2006 | 10 | 0.060 |
Why?
|
| Cell Hypoxia | 2 | 2019 | 7 | 0.060 |
Why?
|
| Amidohydrolases | 1 | 2006 | 2 | 0.060 |
Why?
|
| Arachidonic Acids | 1 | 2006 | 8 | 0.060 |
Why?
|
| Glutamine | 1 | 2025 | 1 | 0.060 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2025 | 1 | 0.060 |
Why?
|
| Phenylthiohydantoin | 1 | 2025 | 2 | 0.060 |
Why?
|
| Benzamides | 1 | 2025 | 11 | 0.060 |
Why?
|
| Receptors, Androgen | 1 | 2025 | 20 | 0.060 |
Why?
|
| Nitriles | 1 | 2025 | 13 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 17 | 0.060 |
Why?
|
| Genes, Immediate-Early | 1 | 2005 | 1 | 0.060 |
Why?
|
| Cross-Sectional Studies | 3 | 2015 | 506 | 0.050 |
Why?
|
| Electron Transport | 1 | 2024 | 2 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 1994 | 12 | 0.050 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2023 | 1 | 0.050 |
Why?
|
| Severity of Illness Index | 3 | 2012 | 118 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2014 | 14 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 268 | 0.050 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2018 | 20 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2003 | 4 | 0.050 |
Why?
|
| Cell Nucleus | 2 | 2007 | 38 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2015 | 63 | 0.050 |
Why?
|
| Armadillo Domain Proteins | 1 | 2023 | 1 | 0.050 |
Why?
|
| Actins | 3 | 2007 | 28 | 0.050 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2002 | 1 | 0.050 |
Why?
|
| Shock, Septic | 1 | 2002 | 4 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2002 | 28 | 0.050 |
Why?
|
| Aspartate Aminotransferases | 1 | 2022 | 6 | 0.050 |
Why?
|
| Platelet Count | 1 | 2022 | 6 | 0.050 |
Why?
|
| ROC Curve | 1 | 2022 | 28 | 0.050 |
Why?
|
| Neoplasms, Experimental | 2 | 2016 | 9 | 0.050 |
Why?
|
| Casein Kinase II | 1 | 2022 | 1 | 0.050 |
Why?
|
| NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2022 | 3 | 0.050 |
Why?
|
| Protein Binding | 1 | 2022 | 29 | 0.050 |
Why?
|
| Adipose Tissue, White | 1 | 2022 | 9 | 0.050 |
Why?
|
| Weight Gain | 1 | 2022 | 28 | 0.050 |
Why?
|
| 14-3-3 Proteins | 1 | 2021 | 2 | 0.040 |
Why?
|
| Polyploidy | 1 | 2021 | 1 | 0.040 |
Why?
|
| Mutation | 1 | 2022 | 97 | 0.040 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2021 | 1 | 0.040 |
Why?
|
| Autophagosomes | 1 | 2021 | 1 | 0.040 |
Why?
|
| Autophagy-Related Proteins | 1 | 2021 | 2 | 0.040 |
Why?
|
| Chlamydia Infections | 1 | 2001 | 8 | 0.040 |
Why?
|
| Lysosomes | 1 | 2021 | 14 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2001 | 15 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2001 | 20 | 0.040 |
Why?
|
| Fishes | 3 | 2000 | 9 | 0.040 |
Why?
|
| Muscles | 3 | 2000 | 19 | 0.040 |
Why?
|
| Coronary Disease | 1 | 2001 | 18 | 0.040 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2020 | 3 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2020 | 4 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2020 | 5 | 0.040 |
Why?
|
| Thiophenes | 1 | 2020 | 3 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2020 | 17 | 0.040 |
Why?
|
| Dipeptides | 1 | 2000 | 6 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 2 | 2010 | 4 | 0.040 |
Why?
|
| Antihypertensive Agents | 1 | 2000 | 56 | 0.040 |
Why?
|
| Gastrinoma | 1 | 2000 | 1 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2014 | 145 | 0.040 |
Why?
|
| Stomach Neoplasms | 1 | 2000 | 11 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 90 | 0.040 |
Why?
|
| RNA | 1 | 2019 | 25 | 0.040 |
Why?
|
| Benzoxazoles | 1 | 2019 | 1 | 0.040 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2019 | 7 | 0.040 |
Why?
|
| Adenoviridae | 2 | 2011 | 8 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2018 | 1 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2019 | 17 | 0.040 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2018 | 2 | 0.040 |
Why?
|
| Hypertension | 1 | 2000 | 147 | 0.040 |
Why?
|
| Dietary Fats | 1 | 2018 | 19 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2018 | 21 | 0.040 |
Why?
|
| Histocytochemistry | 2 | 2014 | 5 | 0.040 |
Why?
|
| Smad Proteins, Receptor-Regulated | 1 | 2018 | 1 | 0.040 |
Why?
|
| Nucleoside-Phosphate Kinase | 1 | 2018 | 1 | 0.040 |
Why?
|
| Biocatalysis | 1 | 2018 | 3 | 0.040 |
Why?
|
| Cholic Acids | 1 | 2018 | 1 | 0.040 |
Why?
|
| Transcriptome | 1 | 2018 | 31 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 9 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 9 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 26 | 0.040 |
Why?
|
| Models, Animal | 2 | 2010 | 23 | 0.030 |
Why?
|
| Tooth Resorption | 1 | 1997 | 1 | 0.030 |
Why?
|
| Tooth, Deciduous | 1 | 1997 | 1 | 0.030 |
Why?
|
| Osteoclasts | 1 | 1997 | 2 | 0.030 |
Why?
|
| Giant Cells | 1 | 1997 | 2 | 0.030 |
Why?
|
| Hydrogen Peroxide | 2 | 2007 | 9 | 0.030 |
Why?
|
| Blood Glucose | 2 | 2010 | 188 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 2 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2008 | 43 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2016 | 4 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2016 | 7 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2016 | 11 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2016 | 10 | 0.030 |
Why?
|
| I-kappa B Kinase | 1 | 2016 | 5 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 6 | 0.030 |
Why?
|
| Liposarcoma, Myxoid | 1 | 1995 | 1 | 0.030 |
Why?
|
| Thoracic Neoplasms | 1 | 1995 | 3 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 26 | 0.030 |
Why?
|
| Angiotensin I | 2 | 2009 | 4 | 0.030 |
Why?
|
| Angiotensin II | 2 | 2009 | 18 | 0.030 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2015 | 4 | 0.030 |
Why?
|
| Transfection | 2 | 2007 | 56 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 42 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 104 | 0.030 |
Why?
|
| Peptides | 1 | 1994 | 19 | 0.030 |
Why?
|
| Necrosis | 2 | 2006 | 30 | 0.030 |
Why?
|
| Fats | 1 | 2014 | 1 | 0.030 |
Why?
|
| Radiography | 1 | 2014 | 20 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2014 | 2 | 0.030 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2014 | 5 | 0.030 |
Why?
|
| Lipogenesis | 1 | 2014 | 6 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 1 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 2 | 0.030 |
Why?
|
| California | 1 | 2015 | 230 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2014 | 19 | 0.030 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2014 | 1 | 0.030 |
Why?
|
| Mitosis | 1 | 2014 | 2 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2014 | 1 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 19 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2014 | 16 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2014 | 40 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 82 | 0.030 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2013 | 1 | 0.030 |
Why?
|
| Calgranulin A | 1 | 2013 | 1 | 0.030 |
Why?
|
| Wound Healing | 1 | 2013 | 14 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2014 | 102 | 0.030 |
Why?
|
| Hepatitis C | 1 | 2013 | 19 | 0.030 |
Why?
|
| Bacillus | 1 | 1993 | 1 | 0.030 |
Why?
|
| Antigens, CD1d | 2 | 2004 | 2 | 0.020 |
Why?
|
| Fas Ligand Protein | 2 | 2003 | 3 | 0.020 |
Why?
|
| Hydrolysis | 3 | 2000 | 5 | 0.020 |
Why?
|
| Receptors, CXCR4 | 1 | 2012 | 4 | 0.020 |
Why?
|
| Ischemia | 1 | 2012 | 7 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2012 | 17 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2012 | 9 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 127 | 0.020 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 2011 | 2 | 0.020 |
Why?
|
| Fructose | 1 | 2011 | 6 | 0.020 |
Why?
|
| Kynurenine | 1 | 2011 | 3 | 0.020 |
Why?
|
| Serotonin | 1 | 2011 | 5 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2012 | 101 | 0.020 |
Why?
|
| Animal Feed | 1 | 2011 | 11 | 0.020 |
Why?
|
| Lipids | 1 | 2011 | 35 | 0.020 |
Why?
|
| NADPH Oxidase 1 | 1 | 2011 | 1 | 0.020 |
Why?
|
| NADPH Oxidase 2 | 1 | 2011 | 2 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2010 | 1 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2010 | 10 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 285 | 0.020 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2010 | 1 | 0.020 |
Why?
|
| Glycogen | 1 | 2010 | 10 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2010 | 9 | 0.020 |
Why?
|
| Transplantation Chimera | 1 | 2010 | 1 | 0.020 |
Why?
|
| Methionine | 1 | 2010 | 2 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2010 | 11 | 0.020 |
Why?
|
| Glucose | 1 | 2010 | 50 | 0.020 |
Why?
|
| Renin-Angiotensin System | 1 | 2009 | 7 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2009 | 2 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 11 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 45 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2009 | 23 | 0.020 |
Why?
|
| Chimera | 1 | 2009 | 1 | 0.020 |
Why?
|
| Hepatitis, Chronic | 1 | 2009 | 1 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2009 | 1 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2009 | 15 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2009 | 30 | 0.020 |
Why?
|
| Cocarcinogenesis | 1 | 2009 | 1 | 0.020 |
Why?
|
| Nanog Homeobox Protein | 1 | 2009 | 2 | 0.020 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2009 | 2 | 0.020 |
Why?
|
| Janus Kinases | 1 | 2008 | 3 | 0.020 |
Why?
|
| Receptor, TIE-2 | 1 | 2008 | 1 | 0.020 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2008 | 7 | 0.020 |
Why?
|
| Gene Expression | 1 | 2008 | 77 | 0.020 |
Why?
|
| Occult Blood | 1 | 2007 | 4 | 0.020 |
Why?
|
| Rectum | 1 | 2007 | 8 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2007 | 13 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2007 | 21 | 0.020 |
Why?
|
| Sendai virus | 1 | 2007 | 1 | 0.020 |
Why?
|
| Liposomes | 1 | 2007 | 6 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2007 | 5 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2007 | 7 | 0.020 |
Why?
|
| Palliative Care | 1 | 2007 | 22 | 0.020 |
Why?
|
| Hepatectomy | 1 | 2007 | 1 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2007 | 25 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2007 | 2 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 14 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 29 | 0.020 |
Why?
|
| Desmin | 1 | 2006 | 1 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2006 | 2 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2006 | 2 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2006 | 27 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2006 | 22 | 0.020 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2006 | 2 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2006 | 19 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2006 | 4 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 12 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 2006 | 11 | 0.020 |
Why?
|
| Probability | 1 | 2006 | 20 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2006 | 42 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2006 | 63 | 0.020 |
Why?
|
| Fatty Acid Transport Proteins | 1 | 2006 | 1 | 0.020 |
Why?
|
| Cholesterol | 1 | 2006 | 37 | 0.020 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2006 | 3 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 118 | 0.020 |
Why?
|
| Endocannabinoids | 1 | 2006 | 4 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2006 | 8 | 0.020 |
Why?
|
| Glutathione | 1 | 2006 | 14 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 497 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 155 | 0.010 |
Why?
|
| Prognosis | 1 | 2006 | 220 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2006 | 197 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 39 | 0.010 |
Why?
|
| Parasitemia | 1 | 2004 | 1 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2004 | 5 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2004 | 18 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2004 | 21 | 0.010 |
Why?
|
| Injections | 1 | 2004 | 20 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2004 | 14 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1994 | 38 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2004 | 4 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1994 | 70 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 25 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2006 | 500 | 0.010 |
Why?
|
| Crohn Disease | 1 | 2003 | 5 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 10 | 0.010 |
Why?
|
| Viral Core Proteins | 1 | 2003 | 1 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2003 | 1 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2003 | 5 | 0.010 |
Why?
|
| Propionibacterium acnes | 1 | 2003 | 3 | 0.010 |
Why?
|
| Genome | 1 | 2003 | 7 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 23 | 0.010 |
Why?
|
| Transcription Factor RelA | 1 | 2003 | 7 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 2002 | 3 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 2002 | 6 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2002 | 10 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 38 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2001 | 2 | 0.010 |
Why?
|
| Perforin | 1 | 2001 | 5 | 0.010 |
Why?
|
| fas Receptor | 1 | 2001 | 3 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 2001 | 2 | 0.010 |
Why?
|
| Chlamydia | 1 | 2001 | 2 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 2001 | 4 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 2001 | 5 | 0.010 |
Why?
|
| Seroepidemiologic Studies | 1 | 2001 | 10 | 0.010 |
Why?
|
| Japan | 1 | 2001 | 6 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2001 | 19 | 0.010 |
Why?
|
| Aldosterone | 1 | 2000 | 8 | 0.010 |
Why?
|
| Reference Values | 1 | 2000 | 56 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2001 | 46 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2000 | 101 | 0.010 |
Why?
|
| Gastrins | 1 | 2000 | 4 | 0.010 |
Why?
|
| Gastrectomy | 1 | 2000 | 4 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2000 | 57 | 0.010 |
Why?
|
| Tartrate-Resistant Acid Phosphatase | 1 | 1997 | 1 | 0.010 |
Why?
|
| Acid Phosphatase | 1 | 1997 | 5 | 0.010 |
Why?
|
| Cell Count | 1 | 1997 | 18 | 0.010 |
Why?
|
| Child | 1 | 1997 | 524 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1994 | 34 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1993 | 1 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1993 | 18 | 0.010 |
Why?
|